Port Jefferson, NY, United States of America

Matthew Ronsheim

USPTO Granted Patents = 7 

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2009-2017

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Matthew Ronsheim

Introduction

Matthew Ronsheim is a notable inventor based in Port Jefferson, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of beta-arrestin effectors. With a total of 7 patents to his name, Ronsheim's work has implications for various therapeutic applications.

Latest Patents

Ronsheim's latest patents include the "Synthesis of beta-arrestin effectors," which provides compounds and methods for preparing beta-arrestin effectors. Another significant patent is for "Crystalline and amorphous forms of a β-arrestin effector," which discloses novel crystalline forms of a compound that acts as a β-arrestin effector, along with processes for preparing these forms and their uses.

Career Highlights

Throughout his career, Ronsheim has worked with prominent companies in the pharmaceutical industry, including Forest Laboratories Holdings Limited and Trevena, Inc. His expertise in the field has allowed him to contribute to innovative projects that advance medical science.

Collaborations

Ronsheim has collaborated with talented individuals such as Gian-Luca Araldi and Melanie Simone Ronsheim. These partnerships have fostered a creative environment that enhances the development of new technologies.

Conclusion

Matthew Ronsheim's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…